<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03644654</url>
  </required_header>
  <id_info>
    <org_study_id>UHospital Hradec Kralove</org_study_id>
    <nct_id>NCT03644654</nct_id>
  </id_info>
  <brief_title>Perioperative Fluid Therapy Optimization in Spinal Surgery</brief_title>
  <official_title>Perioperative Fluid Therapy Optimization in Spinal Surgery Using Non-invasive Measurement of Haemodynamics (ClearSight System, Edwards); a Comparison to Standard Method</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Hradec Kralove</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Hradec Kralove</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The decision to give fluids perioperatively could be based on methods used to identify
      preload responsiveness, either invasive or noninvasive estimates of stroke volume variation
      during mechanical ventilation. This study compares fluid management using continuous
      noninvasive cardiac output measurement with standard perioperative fluid management.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to optimise fluid managemet and to reduce perioperative risks during
      spinal procedures in prone position. Adequate perioperative management guided by hemodynamic
      monitoring can help to reduce the risk of complications and thus potentially improve
      outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 21, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative fluid balance</measure>
    <time_frame>5 hours</time_frame>
    <description>the difference between fluid intake and output and losses during surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mean dose of norepinephrine</measure>
    <time_frame>5 hours</time_frame>
    <description>mean dose of norepinephrine wil be calculated as total intraoperative norepinephrine dose devided by the lenght of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of creatinine</measure>
    <time_frame>24 hours</time_frame>
    <description>plasma level of creatinine measured on the first postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pooperative lung dysfunction</measure>
    <time_frame>24 hours</time_frame>
    <description>postoperative lung dysfunction defined as SpO2 value less than 92% or oxygen therapy for more than 6 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the length of postoperative stay</measure>
    <time_frame>till 2 months after surgery</time_frame>
    <description>the length of postoperative stay in hospital</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Hypovolemia</condition>
  <condition>Hypervolemia</condition>
  <arm_group>
    <arm_group_label>Standard care group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluid management will be done according standard care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Noninvasive monitoring group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fluid management will be provided using noninvasive hemodynamical monitor ClearSight (Edwards)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard care group</intervention_name>
    <description>Patient will receive 2 ml/kg/hour of crystalloids (Ringerfundin BBraun) intraoperatively. Fluid boluses will be used according to anesthesiologists decision (timing and amount of fluids). In case of drop of mean arterial pressure (MAP) below 65 mmHg norepinephrine will be started (with initial bolus of 5 - 10 ug).</description>
    <arm_group_label>Standard care group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Noninvasive monitoring group</intervention_name>
    <description>Patient will receive 2 ml/kg/hour of crystalloids (Ringerfundin BBraun) intraoperatively. In case of hypotension (defined as a mean arterial pressure below 65 mmHg), the intervention will be led according to a protocol based on cardiac index, systemic vascular resitance and stroke volume variation (SVV) values (ClearSight, Edwards).</description>
    <arm_group_label>Noninvasive monitoring group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Glasgow Coma scale 15

          -  ASA Physical Status Classification System I-III

          -  planed spinal surgery to 3 hours

          -  postoperative awakening

          -  sinus rhythm

        Exclusion Criteria:

          -  NYHA III, IV

          -  BMI over 40 in females and over 35 in men

          -  awake operation

          -  postoperative artificial ventilation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pavel Dostal, MD, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Hradec Kralove</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50005</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 21, 2018</study_first_submitted>
  <study_first_submitted_qc>August 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2018</study_first_posted>
  <last_update_submitted>May 25, 2020</last_update_submitted>
  <last_update_submitted_qc>May 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Hradec Kralove</investigator_affiliation>
    <investigator_full_name>Dostalova Vlasta, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>fluid responsiveness, haemodynamical monitoring, ClearSight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypovolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

